Cargando…
Immunocytochemistry of cytology specimens for predictive biomarkers in lung cancer
With a growing number of predictive biomarkers that have emerged in non-small cell lung carcinoma (NSCLC), there has been a paradigm shift in the management of these patients. Of the various predictive biomarker testing methods, immunohistochemistry (IHC) is the most widely available, cost-effective...
Autor principal: | Roy-Chowdhuri, Sinchita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354113/ https://www.ncbi.nlm.nih.gov/pubmed/32676355 http://dx.doi.org/10.21037/tlcr.2019.12.31 |
Ejemplares similares
-
Lung cancer biomarker testing: perspective from Europe
por: Thunnissen, Erik, et al.
Publicado: (2020) -
Lung cancer biomarker tests: the history and perspective in Japan
por: Motoi, Noriko, et al.
Publicado: (2020) -
Integrative approach to cytologic and molecular diagnosis of malignant pleural mesothelioma
por: Hjerpe, Anders, et al.
Publicado: (2020) -
Significance of tumor spread through air spaces (STAS) in lung cancer from the pathologist perspective
por: Mino-Kenudson, Mari
Publicado: (2020) -
Selected highlights of the 2019 Pulmonary Pathology Society Biennial Meeting
por: Dacic, Sanja
Publicado: (2020)